Apoptin Inhibits Glycolysis and Regulates Autophagy by Targeting Pyruvate Kinase M2 (PKM2) in Lung Cancer A549 Cells

被引:2
|
作者
Song, Gaojie [1 ,2 ,3 ]
Shang, Chao [2 ]
Zhu, Yilong [3 ]
Xiu, Zhiru [3 ]
Li, Yaru [3 ]
Yang, Xia [3 ]
Ge, Chenchen [3 ]
Han, Jicheng [3 ]
Jin, Ningyi [2 ,3 ]
Li, Yiquan [3 ]
Li, Xiao [2 ,3 ]
Fang, Jinbo [3 ]
机构
[1] Jiujiang Univ, Med Coll, Jiujiang 332000, Peoples R China
[2] Chinese Acad Agr Sci, Changchun Vet Res Inst, Changchun 130117, Peoples R China
[3] Changchun Univ Chinese Med, Academician Workstat Jilin Prov, Changchun 130122, Peoples R China
关键词
Apoptin; PKM2; glycolysis; autophagy; lung cancer; energy metabolism; MIGRATION; PROTEIN; PROLIFERATION; APOPTOSIS; INVASION; VIRUS; MTOR;
D O I
10.2174/1568009623666221025150239
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Pyruvate kinase M2 (PKM2) is a key enzyme in aerobic glycolysis and plays an important role in tumor energy metabolism and tumor growth. Ad-apoptin, a recombinant oncolytic adenovirus, can stably express apoptin in tumor cells and selectively causes cell death in tumor cells.Objective The relationship between the anti-tumor function of apoptin, including apoptosis and autophagy activation, and the energy metabolism of tumor cells has not been clarified.Methods In this study, we used the A549 lung cancer cell line to analyze the mechanism of PKM2 involvement in apoptin-mediated cell death in tumor cells. PKM2 expression in lung cancer cells was detected by Western blot and qRT-PCR. In the PKM2 knockdown and over-expression experiments, A549 lung cancer cells were treated with Ad-apoptin, and cell viability was determined by the CCK-8 assay and crystal violet staining. Glycolysis was investigated using glucose consumption and lactate production experiments. Moreover, the effects of Ad-apoptin on autophagy and apoptosis were analyzed by immunofluorescence using the Annexin v-mCherry staining and by western blot for c-PARP, p62, and LC3-II proteins. Immunoprecipitation analysis was used to investigate the interaction between apoptin and PKM2. In addition, following PKM2 knockdown and overexpression, the expression levels of p-AMPK, p-mTOR, p-ULK1, and p-4E-BP1 proteins in Ad-apoptin treated tumor cells were analyzed by western blot to investigate the mechanism of apoptin effect on the energy metabolism of tumor cells. The in vivo antitumor mechanism of apoptin was analyzed by xenograft tumor inhibition experiment in nude mice and immunohistochemistry of tumors' tissue.Results As a result, apoptin could target PKM2, inhibit glycolysis and cell proliferation in A549 cells, and promote autophagy and apoptosis in A549 cells by regulating the PKM2/AMPK/mTOR pathway.Conclusion This study confirmed the necessary role of Ad-apoptin in the energy metabolism of A549 cells.
引用
收藏
页码:411 / 424
页数:14
相关论文
共 50 条
  • [21] Association of Phosphorylated Pyruvate Dehydrogenase with Pyruvate Kinase M2 Promotes PKM2 Stability in Response to Insulin
    Hossain, Abu Jubayer
    Islam, Rokibul
    Seo, Jong-Bok
    Park, Hwee-Seon
    Kim, Jong-Il
    Kumar, Vikas
    Lee, Keun Woo
    Park, Jae-Bong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (18)
  • [22] The M2 isoform of pyruvate kinase (PKM2) contributes to leukemia stem cell persistence by maintaining oxidative homeostasis and promoting glycolysis
    Sturgill, Eric M.
    Guzman, Monica L.
    CANCER RESEARCH, 2014, 74 (19)
  • [23] Small ubiquitin-like modifier 1 modification of pyruvate kinase M2 promotes aerobic glycolysis and cell proliferation in A549 human lung cancer cells
    An, Shuxian
    Huang, Liangqin
    Miao, Ping
    Shi, Liang
    Shen, Mengqin
    Zhao, Xiaoping
    Liu, Jianjun
    Huang, Gang
    ONCOTARGETS AND THERAPY, 2018, 11 : 2097 - 2109
  • [24] Pyruvate Kinase M2 (PKM2) Activation in the Podocyte Prevented Subset Differentiation of Glomerular Cells Induced by Diabetes
    Fu, Jialin
    Li, Qian
    Park, Kyoungmin
    Shinjo, Takanori
    Huang, Qian
    Wu, I-Hsien
    King, George L.
    DIABETES, 2024, 73
  • [25] Identification of a new pyruvate kinase M2 isoform (PKM2) activator for the treatment of non-small-cell lung cancer (NSCLC)
    Li, Run-Ze
    Fan, Xing-Xing
    Shi, Dan-Feng
    Zhu, Guo-Yuan
    Wang, Yu-Wei
    Luo, Lian-Xiang
    Pan, Hu-Dan
    Yao, Xiao-Jun
    Leung, Elaine Lai-Han
    Liu, Liang
    CHEMICAL BIOLOGY & DRUG DESIGN, 2018, 92 (05) : 1851 - 1858
  • [26] Elevation of serum pyruvate kinase M2 (PKM2) in IBD and its relationship to IBD indices
    Almousa, Ahmed A.
    Morris, Marc
    Fowler, Sharyle
    Jones, Jennifer
    Alcorn, Jane
    CLINICAL BIOCHEMISTRY, 2018, 53 : 19 - 24
  • [27] Activation of Pyruvate Kinase M2 (PKM2) attenuates inflammatory response in experimental bacterial endophthalmitis
    Singh, Sukhvinder
    Ahmad, Zeeshan
    Das, Susmita
    Kumar, Ashok
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [28] Non-metabolic functions of pyruvate kinase M2: PKM2 in tumorigenesis and therapy resistance
    Ilhan, Mustafa
    NEOPLASMA, 2022, 69 (04) : 747 - 754
  • [29] MUC1-C Oncoprotein Regulates Glycolysis and Pyruvate Kinase m2 Activity in Cancer Cells
    Kosugi, Michio
    Ahmad, Rehan
    Alam, Maroof
    Uchida, Yasumitsu
    Kufe, Donald
    PLOS ONE, 2011, 6 (11):
  • [30] Enhanced expression of PKM2 associates with the biological properties of cancer stem cells from A549 human lung cancer cells
    Guo, Chang-Ying
    Yan, Chen
    Luo, Lan
    Goto, Shinji
    Urata, Yoshishige
    Xu, Jian-Jun
    Wen, Xiao-Ming
    Kuang, Yu-Kang
    Tou, Fang -Fang
    Li, Tao-Sheng
    ONCOLOGY REPORTS, 2017, 37 (04) : 2161 - 2166